AGA Clinical Practice Update on Ascites, Volume Overload, and Hyponatremia in Cirrhosis

The American Gastroenterological Association (AGA) Clinical Practice Update on Ascites, Volume Overload, and Hyponatremia in Cirrhosis provides evidence-based guidance on the management of these complications in patients with cirrhosis. Below is a detailed summary of the key points from the update:

### **1. Volume Overload in Cirrhosis**

• **Hallmarks:** Ascites, hepatic hydrothorax, peripheral edema, and anasarca are defining features of decompensated cirrhosis caused by portal hypertension.
• **Pathophysiology:** Portal hypertension leads to neurohormonal activation, which drives renal sodium and water retention, intravascular hypovolemia, and fluid redistribution.
• **Impact on Quality of Life:** Volume overload is associated with frequent hospitalizations, reduced quality of life, and increased mortality.

### **2. Ascites Management**

• **First-Line Treatment:**
• **Dietary Sodium Restriction:** Sodium restriction is critical for managing ascites. Early referral to a dietitian is recommended to ensure adequate nutrition while achieving sodium restriction.
• **Diuretics:** Spironolactone and furosemide are used in combination, typically in a 100:40 mg ratio, to improve natriuresis while maintaining electrolyte balance.
• **Weight Targets for Diuresis:**
• Safe diuresis targets are 0.5 kg/day in patients without peripheral edema and up to 1 kg/day in patients with peripheral edema.
• **Diagnostic Paracentesis:**
• All hospitalized patients with new or worsening ascites should undergo prompt diagnostic paracentesis to evaluate for spontaneous bacterial peritonitis (SBP).
• Ascitic fluid analysis (cell count and cultures) is essential for diagnosing SBP, even in asymptomatic patients.
• **Refractory Ascites:**
• Defined as ascites that is unresponsive or intolerant to diuretics and requires repeated therapeutic paracentesis.
• Intravenous albumin is recommended when removing more than 5 L of ascites to prevent circulatory dysfunction.
• **TIPS Procedure:**
• Transjugular intrahepatic portosystemic shunt (TIPS) should be considered for selected patients with refractory ascites, hepatic hydrothorax, or hyponatremia.

### **3. Hepatic Hydrothorax**

• **Prognosis:** Hepatic hydrothorax is associated with worse outcomes compared to refractory ascites.
• **Management:**
• Symptomatic hepatic hydrothorax requires thoracentesis for both diagnostic purposes and symptom relief.
• **Transplant Referral:** All patients with hepatic hydrothorax should be evaluated for liver transplantation, irrespective of their MELD score.

### **4. Hyponatremia in Cirrhosis**

• **Prevalence and Pathophysiology:** Hyponatremia in cirrhosis is usually hypervolemic and reflects advanced circulatory dysfunction.
• **Diagnostic Workup:** Comprehensive evaluation includes assessing medications, renal function, infections, and endocrine disorders.
• **Management:**
• **Outpatient Care:** Asymptomatic patients can be managed with fluid restriction, diuretic adjustments, and close monitoring.
• **Inpatient Care:** Severe or symptomatic hyponatremia requires hospitalization, fluid restriction, intravenous albumin, or vasoconstrictors.
• **Multidisciplinary Approach:** Refractory hyponatremia requires coordinated care involving hepatology, nephrology, and transplant teams.

### **5. Liver Transplantation**

• **Universal Referral:** All patients with ascites or hepatic hydrothorax should be evaluated for liver transplantation, regardless of their MELD score.

### **6. Multidisciplinary Management**

• Patients with refractory volume overload or hyponatremia benefit from a collaborative approach involving hepatologists, nephrologists, dietitians, and transplant teams for optimal care.

### **Conclusion**

The AGA guidelines emphasize a structured approach to managing ascites, volume overload, and hyponatremia in cirrhosis. Early intervention, patient-centered care, and multidisciplinary collaboration are essential to improve outcomes and quality of life for affected patients.